99 related articles for article (PubMed ID: 8082575)
41. Low-birth-weight infant with Antley-Bixler syndrome-like phenotype caused by POR mutation: a rare case report.
Imataka G; Fujisawa M; Kuribayashi R; Ichikawa G; Watabe Y; Suzumura H; Arisaka O; Yoshihara S
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):11998-12000. PubMed ID: 33336784
[No Abstract] [Full Text] [Related]
42. N-acetyltransferase phenotypes of bladder cancer patients in a low-risk population.
Mommsen S; Sell A; Barfod N
Lancet; 1982 Nov; 2(8309):1228. PubMed ID: 6128543
[No Abstract] [Full Text] [Related]
43. Foreword.
Hrycay EG; Bandiera SM
Adv Exp Med Biol; 2015; 851():v-vii. PubMed ID: 26380853
[No Abstract] [Full Text] [Related]
44. Genetic association with bladder cancer.
Wolf H
Br Med J; 1979 Nov; 2(6201):1366. PubMed ID: 519454
[No Abstract] [Full Text] [Related]
45. Update information on human P450s.
Guengerich FP
Drug Metab Rev; 2002; 34(1-2):7-15. PubMed ID: 11996014
[No Abstract] [Full Text] [Related]
46. Polymorphism in human N-acetyltransferase--the case of the missing allele.
Sime E; Hickman D
Trends Pharmacol Sci; 1991 Jun; 12(6):211-3. PubMed ID: 2048215
[No Abstract] [Full Text] [Related]
47. Authors' response.
Ramzi N; Chahil J; Lye S; Metnam K; Sahadevappa K; Velapasamy S; Hashim N; Cheah S; Lim G; Hussein H; Haron M; Alex L; Ler LW
Indian J Med Res; 2015 Feb; 141(2):246. PubMed ID: 26080469
[No Abstract] [Full Text] [Related]
48. Matching for risk factors in case control studies.
Kaushal K
Indian J Med Res; 2015 Feb; 141(2):245. PubMed ID: 25900963
[No Abstract] [Full Text] [Related]
49. Food-derived compounds for CYP-phenotyping.
Haschke M
Br J Clin Pharmacol; 2024 Mar; 90(3):713-714. PubMed ID: 38212061
[No Abstract] [Full Text] [Related]
50. Validating phenotyping cocktails: more work needs to be done.
Ma JD; Nafziger AN; Bertino JS
J Clin Pharmacol; 2012 Nov; 52(11):1772-3; author reply 1774-5. PubMed ID: 23105127
[No Abstract] [Full Text] [Related]
51. Within species expressed genetic variability and gene expression response to different temperatures in the rotifer Brachionus calyciflorus sensu stricto.
Paraskevopoulou S; Dennis AB; Weithoff G; Hartmann S; Tiedemann R
PLoS One; 2019; 14(9):e0223134. PubMed ID: 31568501
[TBL] [Abstract][Full Text] [Related]
52. Risk of Lung Cancer in Workers Exposed to Benzidine and/or Beta-Naphthylamine: A Systematic Review and Meta-Analysis.
Tomioka K; Saeki K; Obayashi K; Kurumatani N
J Epidemiol; 2016 Sep; 26(9):447-58. PubMed ID: 26947956
[TBL] [Abstract][Full Text] [Related]
53. Influence of polymorphic metabolic enzymes on biotransformation and effects of diphenylmethane diisocyanate.
Littorin M; Hou S; Broberg K; Björk J; Fält S; Abdoulaye G; Kalemba M; Ryk C; Skerfving S
Int Arch Occup Environ Health; 2008 Feb; 81(4):429-41. PubMed ID: 17676332
[TBL] [Abstract][Full Text] [Related]
54. PCB exposure and in vivo CYP1A2 activity among Native Americans.
Fitzgerald EF; Hwang SA; Lambert G; Gomez M; Tarbell A
Environ Health Perspect; 2005 Mar; 113(3):272-7. PubMed ID: 15743714
[TBL] [Abstract][Full Text] [Related]
55. Nonparametric expectation maximisation (NPEM) population pharmacokinetic analysis of caffeine disposition from sparse data in adult caucasians: systemic caffeine clearance as a biomarker for cytochrome P450 1A2 activity.
Terziivanov D; Bozhinova K; Dimitrova V; Atanasova I
Clin Pharmacokinet; 2003; 42(15):1393-409. PubMed ID: 14674790
[TBL] [Abstract][Full Text] [Related]
56. Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer.
Tsukino H; Kuroda Y; Nakao H; Imai H; Inatomi H; Osada Y; Katoh T
J Cancer Res Clin Oncol; 2004 Feb; 130(2):99-106. PubMed ID: 14648207
[TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetics of a novel N-methyl-D-aspartate receptor antagonist (SM-18400): identification of an N-acetylated metabolite and pre-clinical assessment of N-acetylation polymorphism.
Yabuki M; Kon-Ya Y; Kataoka M; Shimizudani T; Akao K; Ito M; Kanamaru H; Nakatsuka I
Eur J Drug Metab Pharmacokinet; 2003; 28(1):21-9. PubMed ID: 14503661
[TBL] [Abstract][Full Text] [Related]
58. Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population.
Ou-Yang DS; Huang SL; Wang W; Xie HG; Xu ZH; Shu Y; Zhou HH
Br J Clin Pharmacol; 2000 Feb; 49(2):145-51. PubMed ID: 10671909
[TBL] [Abstract][Full Text] [Related]
59. Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.
Pirmohamed M; Madden S; Park BK
Clin Pharmacokinet; 1996 Sep; 31(3):215-30. PubMed ID: 8877251
[TBL] [Abstract][Full Text] [Related]
60. Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease.
Takakubo F; Yamamoto M; Ogawa N; Yamashita Y; Mizuno Y; Kondo I
J Neural Transm (Vienna); 1996; 103(7):843-9. PubMed ID: 8872868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
